Wojcicki: How 23andMe Disrupts Health Care With DNA

Wojcicki: How 23andMe Disrupts Health Care With DNA Play

Nov. 26 (Bloomberg) -- Anne Wojcicki, CEO & co-founder at 23andMe, discusses the company’s battle with the FDA over their $99 DNA testing product and the company’s plans for growth using big data. She speaks on Bloomberg Television’s “Market Makers.”

  • On Air Now

    Money Clip Watch Now

  • Next

    Bloomberg West

blog comments powered by Disqus